. Author manuscript; available in PMC: 2018 Jan 1.

Published in final edited form as: Clin Nucl Med. 2017 Jan;42(1):e22–e28. doi: 10.1097/RLU.0000000000001379

Table 2.

Test of Significance of Difference in Prognostic Factors Across Categories

Prognostic Factor	Decision Change (n=17) (Mean±SD)	No Decision Change (n=25) (Mean±SD)	P-Value
PSA (ng/ml)	2.09±3.04	2.09±2.92	0.9973
<1	0.42±0.28	0.30±0.22	0.2790
1–<2	1.30±0.40	1.61±0.22	0.3197
≥2	5.56±3.48	7.11±1.86	0.4051
Gleason Score	7.24±0.97	7.36±1.00	0.6882
GS ≤ 3+4	6.71±0.49	6.90±0.88	0.5855
GS ≥ 4+3	7.60±1.08	7.67±0.98	0.8766
Prostatectomy-Fluciclovine Interval (yrs)	2.68±2.72	2.24±3.33	0.6509
≤2	0.50±0.80	0.80±0.78	0.3356
>2	5.50±2.01	6.40±3.44	0.6116